PDF herunterladen
Thromb Haemost 1965; 14(03/04): 332-340
DOI: 10.1055/s-0038-1654872
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

A Case of Fibrin-Stabilizing Factor (FSF) Deficiency

C. J Amris
1   From Department of Clinical Chemistry and Paediatric Department, University Hospital Copenhagen, Denmark
,
L Ranek
1   From Department of Clinical Chemistry and Paediatric Department, University Hospital Copenhagen, Denmark
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
27. Juni 2018 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Summary

A case with congenital deficiency of fibrin-stabilizing factor is reported. Despite severe bleeding tendency the patient had a tonsillectomy and adenotomy without complications under cover of treatment with normal plasma. No familial disposition could be demonstrated.

 

  • References

  • Amris G. J. Investigations concerning the protaminase activity in serum and plasma. Scand. J. clin. Lab. Invest. 14: 105 1962;
    CrossrefPubMedGoogle Scholar
  • Amris G. J, Amris A. The protaminase activity in normal individuals and in medical patients. Scand. J. clin. Lab. Invest. 14: 117 1962;
    CrossrefPubMedGoogle Scholar
  • Amris C. J, Amris A. Investigations concerning activator-free porcine plasmin. Scand. J. clin. Lab. Invest. 15: 189 1963;
    CrossrefPubMedGoogle Scholar
  • Amris C. J, Larsen V, Mogensen B, Storm O. Turnover and distribution of 13iodine-labelled porcine plasmin in man and dog. Dan. med. Bull. 11: 146 1964;
    PubMedGoogle Scholar
  • Biggs R, Douglas A. S. The thromboplastin generation test. J. clin. Path. 06: 23 1953;
    CrossrefPubMedGoogle Scholar
  • Biggs R, Macfarlane R. G. Human Blood Coagulation and Its Disorders. Third Edit. Blackwell Scientific Publications; Oxford.:
    Google Scholar
  • Duckert F, Jung E, Schmerling D. H. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thrombos. Diathes. haemorrh. (Stuttg) 05: 179 1960;
    PubMedGoogle Scholar
  • Gormsen J, Fleischer A. P. Fed. Proc. 22: 2400 1963;
    PubMedGoogle Scholar
  • Hellem A. J. The adhesiveness of human blood platelets in vitro. Scand. J. clin. Lab. Invest. 12. suppl. 51 1960
    PubMedGoogle Scholar
  • Hicks N. D, Pitney W. R. A rapid screening test for disorders of thromboplastin generation. Brit. J. Haemat. 03: 227 1957;
    CrossrefPubMedGoogle Scholar
  • Ikkala E, Nevanlinna H. R. Congenital deficiency of fibrin stabilizing factor. Thrombos. Diathes. haemorrh. (Stuttg) 07: 567 1962;
    PubMedGoogle Scholar
  • Jacobsson K. Studies on fibrinogen. Scand. J. clin. Lab. Invest. Suppl. 14, 1955
    PubMedGoogle Scholar
  • Josso F, Prou-Wartelle Alagille D, Soulier J. P. Le déficit congénital en Facteur Stabilisant de la Fibrine (Facteur XIII). Etude de deux cas. Nouv. Rev. franc. Hémat. 04: 267 1964;
    PubMedGoogle Scholar
  • Laki K, Lorand L. On the solubility of fibrin clots. Science 108: 280 1948;
    CrossrefPubMedGoogle Scholar
  • Laki K. The polymerization of proteins: the action of thrombin on fibrinogen. Arch. Biochem. 32: 317 1951;
    CrossrefPubMedGoogle Scholar
  • Lorand L. Fibrin clots. Nature 166: 694 1950;
    CrossrefPubMedGoogle Scholar
  • Nilsson I. M, Blombäck M, von Francken I. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta med. scand. 159: 35 1957;
    PubMedGoogle Scholar
  • Nilsson I. M, Olow B. Fibrinolysis induced by streptokinase in man. Acta chir. scand. 123: 247 1962;
    PubMedGoogle Scholar
  • Mandelli F. Sindrome emorragica da difetto del Fattore stabilizzante fibrinico di Laki e Lorand. Med. clin. sper. 13: 175 1963;
    PubMedGoogle Scholar
  • Masure R. Trouble congénital de l’hémostase associé à un deficit en Facteur Stabilisant de la Fibrine (F. S. F.). Hémostase. 03: 119 1963;
    PubMedGoogle Scholar
  • Ollendorff P. Improvements in the thrombin generation test. Thrombos. Diathes. haemorrh. (Stuttg) 04: 244 1960;
    PubMedGoogle Scholar
  • Owren P. A, Aas K. The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand. J. clin. Lab. Invest. 03: 201 1951;
    CrossrefPubMedGoogle Scholar
  • Quick A. J. On quantitative estimation of prothrombin. Amer. J. clin. Path. 15: 560 1945;
    PubMedGoogle Scholar
  • Wolf P. A modification for routine laboratory use of Stefanini’s method of estimating factor V activity in human oxalated plasma. J. clin. Path. 06: 34 1953;
    CrossrefPubMedGoogle Scholar